LLY
914.51
+0.93%↑
UNH
577.15
-0.55%↓
NVO
134.78
+2.03%↑
JNJ
164.87
-0.88%↓
ABBV
193.46
+0.25%↑
LLY
914.51
+0.93%↑
UNH
577.15
-0.55%↓
NVO
134.78
+2.03%↑
JNJ
164.87
-0.88%↓
ABBV
193.46
+0.25%↑
LLY
914.51
+0.93%↑
UNH
577.15
-0.55%↓
NVO
134.78
+2.03%↑
JNJ
164.87
-0.88%↓
ABBV
193.46
+0.25%↑
LLY
914.51
+0.93%↑
UNH
577.15
-0.55%↓
NVO
134.78
+2.03%↑
JNJ
164.87
-0.88%↓
ABBV
193.46
+0.25%↑
LLY
914.51
+0.93%↑
UNH
577.15
-0.55%↓
NVO
134.78
+2.03%↑
JNJ
164.87
-0.88%↓
ABBV
193.46
+0.25%↑
Overview
Share price change
24h
Current
Min
10.34
Max
10.78
Recommendations | Buy |
---|---|
12 Months Forecast | +96.21 upside |
Next Earnings | 7 Nov 2024 |
---|
Technical Score
By Trading Central
Confidence
Strong Bullish Evidence
10.26 / 10.42 Support & Resistance
Avita Therapeutics Inc Chart
Past performance is not a reliable indicator of future results.
Related News
19 Sept 2024, 23:50 UTC
Stocks to Watch: Nike, FedEx, Alliance Entertainment Holding, Arq
DJ
Read
19 Sept 2024, 20:59 UTC
FedEx Cuts Full-Year Outlook After Posting Lower Profit, Revenue in 1Q -- Update
DJ
Read
19 Sept 2024, 20:41 UTC
Nike CEO John Donahoe to Retire
DJ
Read
19 Sept 2024, 20:40 UTC
FedEx Cuts Full-Year Outlook After Posting Lower Profit, Revenue in 1Q
DJ
Read
19 Sept 2024, 23:24 UTC
Sims U.S. Business Shines, But Asia Headwinds Remain -- Market Talk
DJ
Read
19 Sept 2024, 23:01 UTC
U.K. Consumers Turn Notably Gloomier, Survey Says
DJ
Read
19 Sept 2024, 22:21 UTC
FedEx Warns of Continued, Worsening Headwinds in 2Q -- Market Talk
DJ
Read
19 Sept 2024, 22:17 UTC
Why Fed Rate Cuts Are Hurting Treasury Bonds -- Barrons.com
DJ
Read
19 Sept 2024, 22:13 UTC
FedEx Counts on Price Hikes to Help Hurting Top and Bottom Lines -- Market Talk
DJ
Read
19 Sept 2024, 22:13 UTC
Global Equities Roundup: Market Talk
DJ
Read
19 Sept 2024, 22:06 UTC
FedEx Stock Is Down. Earnings Show Why The Fed Cut Rates. -- Barrons.com
DJ
Read
19 Sept 2024, 21:46 UTC
FedEx Cuts Full-Year Outlook After Posting Lower Profit, Revenue -- Update
DJ
Read
19 Sept 2024, 21:06 UTC
FedEx Stock Slumps. It Wasn't Just the Earnings That Were Bad. -- Barrons.com
DJ
Read
19 Sept 2024, 20:50 UTC
Tech, Media & Telecom Roundup: Market Talk
DJ
Read
19 Sept 2024, 20:50 UTC
Financial Services Roundup: Market Talk
DJ
Read
19 Sept 2024, 20:50 UTC
Auto & Transport Roundup: Market Talk
DJ
Read
19 Sept 2024, 20:50 UTC
Basic Materials Roundup: Market Talk
DJ
Read
19 Sept 2024, 20:42 UTC
FedEx Stock Skids, Set To Snap Support As Q1 Results Disappoint -- IBD
DJ
Read
19 Sept 2024, 20:39 UTC
Dow, S&P 500 Hit Records After Rate Cut -- WSJ
DJ
Read
19 Sept 2024, 20:12 UTC
FedEx Unable to Provide FY25 EPS or Effective Tax Rate Outlook on GAAP Basis >FDX
DJ
Read
19 Sept 2024, 20:12 UTC
FedEx Cash On-Hand as of Aug 31 Was $5.9 B >FDX
DJ
Read
19 Sept 2024, 20:11 UTC
FedEx Stock Slumps. It Wasn't Just the Earnings That Were Bad. -- Barrons.com
DJ
Read
19 Sept 2024, 20:11 UTC
FedEx: 'Committed to Our Plan to Return $3.8 B to Stockholders This Fiscal Yr' >FDX
DJ
Read
19 Sept 2024, 20:11 UTC
FedEx Expects Recent Pricing Actions to Help Offset Weaker-Than-Expected Demand Trends >FDX
DJ
Read
19 Sept 2024, 20:10 UTC
Dow Crosses 42000, Hits Record in Post-Fed Rally -- WSJ
DJ
Read
19 Sept 2024, 20:10 UTC
FedEx Reaffirms FY25 Capital Spending of $5.2 B >FDX
DJ
Read
19 Sept 2024, 20:10 UTC
FedEx Reaffirms Permanent Cost Reductions From DRIVE Transformation Program of $2.2 B >FDX
DJ
Read
19 Sept 2024, 20:10 UTC
FedEx Had Previously Forecast of Low-To-Mid Single Digit Percentage Increase in Rev for FY25>FDX
DJ
Read
19 Sept 2024, 20:09 UTC
FedEx Sees Low Single-Digit Percentage Rev Growth Rate Yr Over Yr for FY25>FDX
DJ
Read
19 Sept 2024, 20:09 UTC
FedEx Sees FY25 EPS $20 to $21 After Also Excluding Costs Related to Business Optimization Initiatives >FDX
DJ
Read
Peer Comparison
Price change
Avita Therapeutics Inc Forecast
Price Target
By TipRanks
12 Months Forecast
Average 21.25 USD 96.21%
High 40 USD
Low 9 USD
Based on 6 Wall Street analysts offering 12 month price targets forAvita Therapeutics Inc - Dist in the last 3 months.
Rating Consensus
By TipRanks
Buy
6 ratings
4
Buy
2
Hold
0
Sell
Based on 6 analysts giving stock ratings to Avita Therapeutics Inc - Dist in the past 3 months.
Technical Score
By Trading Central
Short Term
Strong Bullish Evidence
Recent bullish events outweigh bearish events.
Intermediate Term
Very Strong Bullish Evidence
Recent bullish events outweigh bearish events.
Long Term
Bullish Evidence
There is one bullish event.